Long COVID's long R&D agenda

Mullard, A

NATURE REVIEWS DRUG DISCOVERY, 2021; 20 (5): 329

Abstract

As researchers work to understand the biology and epidemiology of post-acute COVID-19, a pioneering platform trial is now testing treatments to try to......

Full Text Link